# Midodrine and Fludrocortisone for Vasovagal Syncope

> **NCT04595942** · PHASE3 · UNKNOWN · sponsor: **Tehran Heart Center** · enrollment: 1375 (estimated)

## Conditions studied

- Syncope, Vasovagal

## Interventions

- **DRUG:** Midodrine Hydrochloride Tablets
- **DRUG:** Fludrocortisone Acetate Tablets
- **BEHAVIORAL:** Lifestyle modification

## Key facts

- **NCT ID:** NCT04595942
- **Lead sponsor:** Tehran Heart Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-11-19
- **Primary completion:** 2023-10
- **Final completion:** 2023-12
- **Target enrollment:** 1375 (ESTIMATED)
- **Last updated:** 2021-04-19

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04595942

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04595942, "Midodrine and Fludrocortisone for Vasovagal Syncope". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04595942. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*